| Wade Butaud, MD | |
|
325 W Center St, Spanish Fork, UT 84660-2060 | |
| (801) 798-7301 | |
| (801) 798-8513 |
| Full Name | Wade Butaud |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 325 W Center St, Spanish Fork, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679703094 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 84070728905 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ashley Regional Medical Center | Vernal, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ashley Valley Physician Practice Llc | 4284683947 | 16 |
News Archive
This report from the Kaiser Family Foundation assesses how countries are responding to a GHI principle to address women, girls and gender equality. The report examines country strategies for seven of the eight "GHI Plus" nations: Bangladesh, Ethiopia, Guatemala, Kenya, Mali, Malawi, and Nepal.
A team of seven researchers collaborating from United States and Britain have found a way to use gene therapy to cure a rare form of childhood blindness that occurs due to a genetic predisposition.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.
A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
› Verified 1 days ago
| Entity Name | Ashley Valley Physician Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740482025 PECOS PAC ID: 4284683947 Enrollment ID: O20050119001166 |
News Archive
This report from the Kaiser Family Foundation assesses how countries are responding to a GHI principle to address women, girls and gender equality. The report examines country strategies for seven of the eight "GHI Plus" nations: Bangladesh, Ethiopia, Guatemala, Kenya, Mali, Malawi, and Nepal.
A team of seven researchers collaborating from United States and Britain have found a way to use gene therapy to cure a rare form of childhood blindness that occurs due to a genetic predisposition.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.
A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
› Verified 1 days ago
| Entity Name | Hospitalist Medicine Physicians Of Utah - Tcg, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093294563 PECOS PAC ID: 7719366186 Enrollment ID: O20220615003338 |
News Archive
This report from the Kaiser Family Foundation assesses how countries are responding to a GHI principle to address women, girls and gender equality. The report examines country strategies for seven of the eight "GHI Plus" nations: Bangladesh, Ethiopia, Guatemala, Kenya, Mali, Malawi, and Nepal.
A team of seven researchers collaborating from United States and Britain have found a way to use gene therapy to cure a rare form of childhood blindness that occurs due to a genetic predisposition.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.
A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wade Butaud, MD 325 W Center St, Spanish Fork, UT 84660-2060 Ph: (801) 798-7301 | Wade Butaud, MD 325 W Center St, Spanish Fork, UT 84660-2060 Ph: (801) 798-7301 |
News Archive
This report from the Kaiser Family Foundation assesses how countries are responding to a GHI principle to address women, girls and gender equality. The report examines country strategies for seven of the eight "GHI Plus" nations: Bangladesh, Ethiopia, Guatemala, Kenya, Mali, Malawi, and Nepal.
A team of seven researchers collaborating from United States and Britain have found a way to use gene therapy to cure a rare form of childhood blindness that occurs due to a genetic predisposition.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.
A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
› Verified 1 days ago
Tracy M Frandsen, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 325 W Center St, Spanish Fork, UT 84660 Phone: 801-798-7301 Fax: 801-798-8513 | |
Dr. Robert A Frampton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 24 N 100 E, Spanish Fork, UT 84660 Phone: 801-798-5359 | |
James J Rose Jr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 325 W Center St, Spanish Fork, UT 84660 Phone: 801-798-7301 Fax: 801-798-8513 | |
Dr. Andrew Barclay, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 336 W 100 S, Spanish Fork, UT 84660 Phone: 801-798-7301 Fax: 801-798-8513 | |
Frank J Archer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 N 100 E, Spanish Fork, UT 84660 Phone: 801-465-4896 Fax: 801-465-3267 | |
Jeffrey J Juchau, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 325 W Center St, Spanish Fork, UT 84660 Phone: 801-798-7301 Fax: 801-798-8513 | |
Dr. Randy Roy Lundell, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 954 N 200 E Ste 954, Spanish Fork, UT 84660 Phone: 801-504-6117 Fax: 801-504-6328 |